• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗抑郁药:全科医疗中的耐受性比较

Newer antidepressants: a comparison of tolerability in general practice.

作者信息

Mackay F R, Dunn N R, Martin R M, Pearce G L, Freemantle S N, Mann R D

出版信息

Br J Gen Pract. 1999 Nov;49(448):892-6.

PMID:10818655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1313560/
Abstract

BACKGROUND

An increasing number of antidepressants have been released on the United Kingdom market in recent years, and these are being prescribed more frequently in general practice. Clinical trials suggest that such agents have similar efficacy and the choice of drug is probably based on tolerability, toxicity in overdose, and cost.

AIM

To compare the tolerability and safety profile of six, newly marketed antidepressants used in general practice.

METHOD

Studies have been conducted for six antidepressants: fluoxetine, sertraline, paroxetine, moclobemide, venlafaxine, and nefazodone, using the technique of prescription-event monitoring. Patients were identified using incident dispensed prescription data. Questionnaires were sent to patients' general practitioners six months after the date of first prescription. Questionnaires asked for date of birth, sex, indication for prescribing each drug, and all events entered in the patients' records after the date of first prescription.

RESULTS

Each cohort exceeded 10,000 patients. Nausea/vomiting was the most frequently reported event for all drugs. The difference in incidence rates for drowsiness/sedation, male sexual dysfunction, and hypertension is shown. Mortality data are also reported.

CONCLUSION

Frequently reported events were similar for all six drugs but there were clinically and statistically significant differences for less frequently reported events. The adjusted mortality rate was identical between the six drugs. This study provides valuable comparative data for six, widely used antidepressants in general practice.

摘要

背景

近年来,越来越多的抗抑郁药投放至英国市场,并且在全科医疗中这些药物的处方开具频率越来越高。临床试验表明,此类药物具有相似的疗效,药物选择可能基于耐受性、过量用药时的毒性以及成本。

目的

比较六种全科医疗中常用的新上市抗抑郁药的耐受性和安全性。

方法

采用处方事件监测技术对六种抗抑郁药进行了研究:氟西汀、舍曲林、帕罗西汀、吗氯贝胺、文拉法辛和奈法唑酮。利用首次配药的处方数据识别患者。在首次处方日期六个月后向患者的全科医生发送问卷。问卷询问出生日期、性别、每种药物的处方开具指征以及首次处方日期之后患者记录中录入的所有事件。

结果

每个队列的患者均超过10,000例。恶心/呕吐是所有药物报告最频繁的事件。显示了嗜睡/镇静、男性性功能障碍和高血压的发生率差异。还报告了死亡率数据。

结论

所有六种药物报告频繁的事件相似,但报告较少的事件在临床和统计学上存在显著差异。六种药物的调整死亡率相同。本研究为全科医疗中广泛使用的六种抗抑郁药提供了有价值的比较数据。

相似文献

1
Newer antidepressants: a comparison of tolerability in general practice.新型抗抑郁药:全科医疗中的耐受性比较
Br J Gen Pract. 1999 Nov;49(448):892-6.
2
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
J Clin Psychiatry. 1995;56 Suppl 6:12-21.
3
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.吗氯贝胺、帕罗西汀、舍曲林和文拉法辛治疗期间抗抑郁药引起的性功能障碍。
J Clin Psychiatry. 2000 Apr;61(4):276-81. doi: 10.4088/jcp.v61n0406.
4
Pharmacokinetic interactions of antidepressants.抗抑郁药的药代动力学相互作用。
J Clin Psychiatry. 1998;59 Suppl 10:22-6.
5
Evaluating the tolerability of the newer antidepressants.评估新型抗抑郁药的耐受性。
J Nerv Ment Dis. 1999 Feb;187(2):96-101. doi: 10.1097/00005053-199902000-00005.
6
Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.老年人使用抗抑郁药。奈法唑酮、文拉法辛和吗氯贝胺的现状。
Drugs Aging. 1997 Aug;11(2):119-31. doi: 10.2165/00002512-199711020-00004.
7
Prevalence of sexual dysfunction among newer antidepressants.新型抗抑郁药中性功能障碍的患病率。
J Clin Psychiatry. 2002 Apr;63(4):357-66. doi: 10.4088/jcp.v63n0414.
8
Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.文拉法辛和奈法唑酮,两种药理特性不同的抗抑郁药。
Pharmacotherapy. 1997 May-Jun;17(3):511-30.
9
Safety and tolerability of the new antidepressants.新型抗抑郁药的安全性与耐受性。
J Clin Psychiatry. 1997;58 Suppl 6:26-31.
10
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.抗抑郁药治疗儿童和青少年重性抑郁障碍的疗效和耐受性比较:网状荟萃分析。
Lancet. 2016 Aug 27;388(10047):881-90. doi: 10.1016/S0140-6736(16)30385-3. Epub 2016 Jun 8.

引用本文的文献

1
Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects.在健康正常受试者中,三重再摄取抑制剂SEP - 432与双重再摄取抑制剂度洛西汀的探索性生物标志物研究。
CNS Neurosci Ther. 2016 May;22(5):404-12. doi: 10.1111/cns.12513. Epub 2016 Feb 5.
2
Dynamic pattern of suicide in Australia, 1986-2005: a descriptive-analytic study.1986 - 2005年澳大利亚自杀动态模式:一项描述性分析研究。
BMJ Open. 2014 Jul 29;4(7):e005311. doi: 10.1136/bmjopen-2014-005311.
3
Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.与第二代抗抑郁药相关的与重度抑郁症患者的性功能障碍:来自系统评价和网络荟萃分析的结果。
Drug Saf. 2014 Jan;37(1):19-31. doi: 10.1007/s40264-013-0129-4.
4
Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.第二代抗抑郁药危害的比较风险:一项系统评价与荟萃分析。
Drug Saf. 2008;31(10):851-65. doi: 10.2165/00002018-200831100-00004.
5
Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.一般来说,选择性5-羟色胺再摄取抑制剂(SSRI)或抗抑郁药会增加自杀倾向吗?世界精神病学协会药物精神病学分会:共识声明。
Eur Arch Psychiatry Clin Neurosci. 2008 Aug;258 Suppl 3:3-23. doi: 10.1007/s00406-008-3002-1.
6
Medically serious adverse effects of newer antidepressants.新型抗抑郁药的严重医学不良反应。
Curr Psychiatry Rep. 2008 Jun;10(3):249-57. doi: 10.1007/s11920-008-0041-2.
7
Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.抗抑郁药对抑郁症患者自杀倾向有负面影响的证据存在吗?一项系统综述。
Eur Arch Psychiatry Clin Neurosci. 2006 Dec;256(8):476-96. doi: 10.1007/s00406-006-0689-8. Epub 2006 Dec 1.
8
Older patients' aversion to antidepressants. A qualitative study.老年患者对抗抑郁药的厌恶:一项定性研究
J Gen Intern Med. 2006 Feb;21(2):146-51. doi: 10.1111/j.1525-1497.2005.00296.x. Epub 2005 Dec 7.
9
Antidepressants and suicide: what is the balance of benefit and harm.抗抑郁药与自杀:利弊平衡如何
BMJ. 2004 Jul 3;329(7456):34-8. doi: 10.1136/bmj.329.7456.34.
10
Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis.1991 - 2000年澳大利亚抗抑郁药物处方与自杀之间的关联:趋势分析
BMJ. 2003 May 10;326(7397):1008. doi: 10.1136/bmj.326.7397.1008.

本文引用的文献

1
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies.通过观察性队列研究对氟伏沙明、氟西汀、舍曲林和帕罗西汀进行的比较。
Pharmacoepidemiol Drug Saf. 1997 Jul;6(4):235-46. doi: 10.1002/(SICI)1099-1557(199707)6:4<235::AID-PDS293>3.0.CO;2-3.
2
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance.1996年的处方事件监测(PEM)——一种非干预性观察性队列药物警戒方法。
Pharmacoepidemiol Drug Saf. 1997 Oct;6 Suppl 3:S5-11. doi: 10.1002/(SICI)1099-1557(199710)6:3+<S5::AID-PDS272>3.0.CO;2-F.
3
Adverse reactions to drugs.药物不良反应。
BMJ. 1998 May 16;316(7143):1511-4. doi: 10.1136/bmj.316.7143.1511.
4
ABC of mental health. Depression.心理健康ABC。抑郁症。
BMJ. 1997 Jul 5;315(7099):43-6. doi: 10.1136/bmj.315.7099.43.
5
General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.全科医生对抗抑郁药物耐受性的看法:选择性5-羟色胺再摄取抑制剂与三环类抗抑郁药的比较
BMJ. 1997 Mar 1;314(7081):646-51. doi: 10.1136/bmj.314.7081.646.
6
Nefazodone and akathisia.奈法唑酮与静坐不能。
Biol Psychiatry. 1996 Oct 15;40(8):798-9. doi: 10.1016/0006-3223(96)00268-5.
7
Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-5.1993 - 1995年英国全科医疗中抗抑郁药处方的横断面数据库分析
BMJ. 1996 Oct 5;313(7061):861-2. doi: 10.1136/bmj.313.7061.861.
8
General practice postal surveys: a questionnaire too far?全科医疗邮政调查:问卷是否太过了?
BMJ. 1996 Sep 21;313(7059):732-3; discussion 733-4. doi: 10.1136/bmj.313.7059.732.
9
Hypertension with moclobemide.
Lancet. 1996 May 11;347(9011):1330. doi: 10.1016/s0140-6736(96)90975-7.
10
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.选择性5-羟色胺再摄取抑制剂:疗效与可接受性的荟萃分析
BMJ. 1993 Mar 13;306(6879):683-7. doi: 10.1136/bmj.306.6879.683.